Author Archives: William Looney

Takeda's New Vaccines Division Charts Course to Global Growth

Today’s vaccines business represents an almost perfect world for big Pharma. There is a vast landscape of unmet medical need; lots of new science; longer product life cycles, with low exposure to post-patent generic competition; greater stability in pricing and supply commitments; more cost-effective manufacturing and delivery technologies; and the reputational gains that come from […]
Posted in Global, Strategy | Tagged , , | Leave a comment

FDA’s Patient Outreach: Finding Ties that Bind

Is the FDA doing enough to incorporate the patient perspective in the drug review process? This was the key question considered at a panel of regulatory experts held at last month’s annual BIO International Convention in San Diego. The consensus: while FDA deserves high marks for effort, both in reconciling the diversity of patient organization […]
Posted in Events, FDA, Meetings, Op-Ed, Regulatory, Safety | Tagged , , , | Leave a comment

The Long Tail: Behind This Year's Pharm Exec 50

Therapeutic specialization, competitive differentiation, and a finely-tailored value proposition are creating a new drug world of bespoke market niches—and infinite future possibilities for the best of this year’s Pharma 50. The vigorous return of M&A activity to biopharmaceuticals this year brings us back to the question that industry strategists have been posing for years: is […]
Posted in Op-Ed, Strategy | Tagged , , , , | Leave a comment

Pharm Exec's Brand of the Year Applauds the Old and the New

Pharm Exec’s Brand of the Year award is itself a brand with staying power — our first recipient was Merck’s Gardasil papillomavirus vaccine, which eight years later is still going strong as one of the company’s 10 top-selling products.
Posted in Global, Orphan Drugs, Strategy | Tagged , , , , , | Leave a comment

Middle East Meltdown: Diabetes in the Arab Context

Diabetes, it can be said, is one of the unpleasant side-effects of being human. Few other medical conditions are so heavily influenced by lifestyle and patterns of individual behavior, reinforced by a mix of economic, social and cultural factors.  Nowhere do these form a more potent combination than in the Arab countries of the Middle East, […]
Posted in Global, healthcare, Op-Ed | Tagged , , | 1 Comment
  • Categories

  • Meta